RUNX1 and head and neck squamous cell carcinoma: For instance, in patients with head and neck squamous cell carcinoma (HNSCC), elevated levels of RUNX1 are associated with more advanced disease stages, as indicated by American Joint Committee on Cancer staging, T-staging, and N-staging.